The Ministry of Food and Drug Safety (MFDS) said that Aimmed’s Somzz for treating insomnia was the first digital therapeutics (DTx) device to receive domestic marketing approval at a press briefing on Wednesday.Somzz is a software medical device that implements cognitive behavioral treatment (CBT) t
The combination therapy of Opdivo (nivolumab), immunotherapy of BMS and Ono Pharmaceutical, and Ipsen’s targeted agent Cabometyx (cabozantinib) has demonstrated long-term efficacy in the primary treatment of progressive kidney cancer.On Monday, BMS released the three-year follow-up data of its Chech
With the misuse and abuse of narcotic painkillers emerging as a social problem in Korea, there is a lot of attention on whether non-narcotic painkillers can be a solution.Narcotic analgesics suppress pain transmission to the central nervous system for patients who see little efficacy when taking ace
Korean pharmaceutical and medical industries, including Celltrion, Yonsei University Health System (YUHS), Asan Foundation, and Soon Chun Hyang University Hospital Bucheon, have offered donations or dispatched physicians and nurses to Turkey and Syria to support relief efforts for communities in the
A report showed that prostate cancer patients with vegetarian dietary habits show more than half lower risks of progression and recurrence than meat-eating patients.The American Society of Clinical Oncology (ASCO) noted the result of the study, “Associations between plant-based diets and risk of dis
Amid the impending approval of digital therapeutics (DTx) devices in Korea, a report that examined the rapidly growing global DTx market has been presented, drawing the attention of domestic businesses.The Korea Health Industry Development Institute (KHIDI) released the report on Monday, which analy
GNT Pharma proved the safety and disability improvement of its stroke candidate drug, Nelonemdaz, and announced its phase 3 clinical trial progress at the 2023 International Stroke Conference (ISC) held last week in Dallas, U.S. The results of the phase 2 study showed that 208 moderate or higher-lev
As Samsung Bioepis won in the first trial to invalidate the patent of Alexion's rare intractable blood disease treatment Soliris (ingredient: eculizumab) in Korea, the possibility of Samsung Bioepis launching SB12, a biosimilar referencing Soliris in Korea has increased.To sell biosimilars, which ar
HK inno.N and Daewoong Pharmaceutical are fiercely competing for the overseas advances of the P-CAB (potassium-competitive acid blocker) series of new treatments for gastroesophageal reflux disease (GERD).HK inno. N said Tuesday that its new GERD treatment K-CAB had won a permit from Mexico’s health
A team of researchers at the Korea Institute of Science and Technology (KIST) said they developed a biosensor that can distinguish small molecular neurotransmitters from body fluids like cerebrospinal fluids.Recently, excessive stress and increased life expectancy have caused an increase in mental d
GC said it has entered into a joint sales partnership with Sanofi-Aventis Korea for the sales and marketing of the latter’s antiplatelet drug, Plavix Tab. 75mg, in Korea.Under the accord, GC will be in charge of sales and marketing of Plavix Tab. 75mg, focusing on clinics.Plavix Tab. 75mg is an orig
LegoChem Biosciences said on Monday that it signed a license agreement with Elthera, a Swiss biotechnology company, to develop and commercialize a novel antibody-drug conjugate (ADC) therapy using Elthera’s monoclonal antibody.The licensed asset is a monoclonal antibody with a target expressed in a
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
The Ministry of Food and Drug Safety (MFDS) said on Monday that it will promote international cooperation for the Korean medical device sector at the Global Harmonization Working Party (GHWP) in Riyadh, Saudi Arabia from Monday to Thursday this week.The GHWP is a cooperative organization established
The five-year survival rate of pancreatic cancer in Korea remained surprisingly low at 15.2 percent, compared to the overall survival rate of all cancer was 71.5 percent, according to the government’s latest statistics.What are the reasons for such poor pancreatic cancer treatment outcomes?Professor
The government has reemphasized the need to increase the enrollment quota at medical schools.Meeting with reporters, Vice Minister of Health and Welfare Park Min-soo said the government would push to increase the number of doctors and expand essential healthcare.The Yoon Suk-yeol administration has
While Novartis is spinning off its generic and biosimilar subsidiary Sandoz, the latter’s Korean offshoot reportedly plans to withdraw from the country, drawing attention to its background.That’s because there were cases where business units of large global pharmaceutical companies were reborn as in
Novelty Nobility, a Korean company specializing in antibody new drug development, said on Monday that its U.S. partner, ValenzaBio, was acquired by Acelyrin on Jan. 5.The acquisition is expected to help the clinical development of its autoimmune disease treatment candidate, NN2802, Novelty Nobility
SK Plasma and Hyundai Pharmaceuticals announced on Monday that they signed domestic sales and distribution agreements with Janssen Korea for Dacogen (ingredient: decitabine) and Topamax (ingredient: topiramate) respectively.Both agreements put the companies in charge of domestic distribution, sales,
The lowest court's recent ruling favoring Medytox in a civil lawsuit against Daewoong Pharmaceutical regarding the source of the latter's botulinum toxin (BTX) strain is causing ripples across the botulinum toxin (BTX) industry.Daewoong and its foreign BTX partners, such as Evolus and AEON Biopharma